YARROW BIOSCIENCE, INC. (YARW) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
17/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseYARW / S&P 8.86% / 15.20% |
LoseYARW / S&P YARW unavailable / 15.00% |
LoseYARW / S&P YARW unavailable / 50.40% |
| 2026-Q11/3 |
WinYARW / S&P 3.10% / -4.33% |
LoseYARW / S&P YARW unavailable / 11.30% |
LoseYARW / S&P YARW unavailable / 27.70% |
| 2025-Q41/3 |
WinYARW / S&P 73.13% / 2.65% |
LoseYARW / S&P YARW unavailable / 9.00% |
LoseYARW / S&P YARW unavailable / 13.40% |
| 2025-Q30/3 |
LoseYARW / S&P -79.70% / 8.12% |
LoseYARW / S&P YARW unavailable / 4.61% |
LoseYARW / S&P YARW unavailable / 13.45% |
| 2025-Q20/3 |
LoseYARW / S&P 4.43% / 10.94% |
LoseYARW / S&P -2.06% / 4.83% |
LoseYARW / S&P -551.81% / 10.63% |
| 2025-Q11/3 |
LoseYARW / S&P -52.84% / -4.27% |
WinYARW / S&P 43.03% / 4.98% |
LoseYARW / S&P -18.18% / 10.57% |
| 2024-Q42/3 |
WinYARW / S&P 78.19% / 2.41% |
WinYARW / S&P 18.16% / 5.25% |
LoseYARW / S&P -66.43% / 6.15% |
| 2024-Q31/3 |
LoseYARW / S&P -4.57% / 5.89% |
WinYARW / S&P 39.27% / 5.89% |
LoseYARW / S&P -134.00% / 6.11% |
| 2024-Q21/3 |
LoseYARW / S&P -35.83% / 4.28% |
WinYARW / S&P 19.41% / 5.38% |
LoseYARW / S&P -115.27% / 5.12% |
| 2024-Q12/3 |
WinYARW / S&P 31.76% / 10.56% |
WinYARW / S&P 6.28% / 5.71% |
LoseYARW / S&P -88.38% / 5.59% |
| 2023-Q40/3 |
LoseYARW / S&P -42.33% / 11.69% |
LoseYARW / S&P -11.11% / 6.81% |
LoseYARW / S&P -60.89% / 7.78% |
| 2023-Q31/3 |
WinYARW / S&P -1.46% / -3.27% |
LoseYARW / S&P -52.42% / 7.52% |
LoseYARW / S&P -65.10% / -5.03% |
| 2023-Q21/3 |
WinYARW / S&P 33.12% / 8.74% |
LoseYARW / S&P -42.68% / 9.50% |
LoseYARW / S&P -58.11% / -8.57% |
| 2023-Q11/3 |
WinYARW / S&P 14.07% / 7.50% |
LoseYARW / S&P -54.72% / 10.77% |
LoseYARW / S&P -56.09% / -15.69% |
| 2022-Q40/3 |
LoseYARW / S&P -32.74% / 7.56% |
LoseYARW / S&P -48.76% / 11.88% |
LoseYARW / S&P -72.07% / -17.99% |
| 2022-Q30/3 |
LoseYARW / S&P -42.67% / -4.88% |
LoseYARW / S&P -84.95% / 13.47% |
LoseYARW / S&P -294.54% / -1.41% |
| 2022-Q20/3 |
LoseYARW / S&P -40.15% / -16.10% |
LoseYARW / S&P -91.21% / 13.71% |
LoseYARW / S&P -279.46% / 11.04% |
| 2022-Q10/3 |
LoseYARW / S&P -36.27% / -4.60% |
LoseYARW / S&P -95.49% / 15.97% |
LoseYARW / S&P -336.63% / 42.23% |
| 2021-Q40/3 |
LoseYARW / S&P -26.62% / 11.03% |
LoseYARW / S&P -95.57% / 15.00% |
LoseYARW / S&P YARW unavailable / 96.40% |
| 2021-Q30/3 |
LoseYARW / S&P -60.40% / 0.58% |
LoseYARW / S&P -70.64% / 10.77% |
LoseYARW / S&P YARW unavailable / 69.42% |
| 2021-Q20/3 |
LoseYARW / S&P -48.72% / 8.55% |
LoseYARW / S&P -40.47% / 6.58% |
LoseYARW / S&P YARW unavailable / 51.81% |
| 2021-Q12/3 |
WinYARW / S&P 8.31% / 6.17% |
WinYARW / S&P 933.05% / -1.06% |
LoseYARW / S&P YARW unavailable / 7.39% |
| 2020-Q41/3 |
LoseYARW / S&P -4.82% / 12.15% |
WinYARW / S&P 4638.83% / -3.72% |
LoseYARW / S&P YARW unavailable / -33.42% |
| 2020-Q30/3 |
LoseYARW / S&P -4.05% / 8.93% |
LoseYARW / S&P -349.99% / -2.04% |
LoseYARW / S&P YARW unavailable / -27.10% |
| 2020-Q20/3 |
LoseYARW / S&P -35.45% / 20.54% |
LoseYARW / S&P YARW unavailable / -0.46% |
LoseYARW / S&P YARW unavailable / -27.11% |
| 2020-Q10/3 |
LoseYARW / S&P -42.24% / -19.60% |
LoseYARW / S&P YARW unavailable / 3.47% |
LoseYARW / S&P YARW unavailable / -14.75% |
| 2019-Q40/3 |
LoseYARW / S&P 3.57% / 9.07% |
LoseYARW / S&P YARW unavailable / 5.36% |
LoseYARW / S&P YARW unavailable / 2.99% |
| 2019-Q30/3 |
LoseYARW / S&P -25.21% / 1.70% |
LoseYARW / S&P YARW unavailable / 5.02% |
LoseYARW / S&P YARW unavailable / 0.21% |
| 2019-Q20/3 |
LoseYARW / S&P -23.69% / 4.30% |
LoseYARW / S&P YARW unavailable / 6.64% |
LoseYARW / S&P YARW unavailable / 8.65% |
| 2019-Q11/3 |
WinYARW / S&P 90.53% / 13.65% |
LoseYARW / S&P YARW unavailable / 8.12% |
LoseYARW / S&P YARW unavailable / 14.29% |
| 2018-Q40/3 |
LoseYARW / S&P -58.17% / -13.52% |
LoseYARW / S&P YARW unavailable / 9.05% |
LoseYARW / S&P YARW unavailable / 18.23% |
| 2018-Q31/3 |
WinYARW / S&P 21.31% / 7.71% |
LoseYARW / S&P YARW unavailable / 10.21% |
LoseYARW / S&P YARW unavailable / 19.06% |
| 2018-Q20/3 |
LoseYARW / S&P -78.39% / 3.43% |
LoseYARW / S&P YARW unavailable / 9.03% |
LoseYARW / S&P YARW unavailable / 14.46% |
| 2018-Q10/3 |
LoseYARW / S&P YARW unavailable / -0.76% |
LoseYARW / S&P YARW unavailable / 7.68% |
LoseYARW / S&P YARW unavailable / 12.46% |
| 2017-Q40/3 |
LoseYARW / S&P YARW unavailable / 6.64% |
LoseYARW / S&P YARW unavailable / 7.03% |
LoseYARW / S&P YARW unavailable / 13.82% |
| 2017-Q30/3 |
LoseYARW / S&P YARW unavailable / 4.48% |
LoseYARW / S&P YARW unavailable / 5.68% |
LoseYARW / S&P YARW unavailable / 17.57% |
| 2017-Q20/3 |
LoseYARW / S&P YARW unavailable / 3.09% |
LoseYARW / S&P YARW unavailable / 4.83% |
LoseYARW / S&P YARW unavailable / 17.74% |
| 2017-Q10/3 |
LoseYARW / S&P YARW unavailable / 6.07% |
LoseYARW / S&P YARW unavailable / 3.67% |
LoseYARW / S&P YARW unavailable / 13.32% |
| 2016-Q40/3 |
LoseYARW / S&P YARW unavailable / 3.82% |
LoseYARW / S&P YARW unavailable / 2.09% |
LoseYARW / S&P YARW unavailable / 7.05% |
| 2016-Q30/3 |
LoseYARW / S&P YARW unavailable / 3.85% |
LoseYARW / S&P YARW unavailable / 0.20% |
LoseYARW / S&P YARW unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | YARW total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 319.44% | 20.78% |
| Annualized return | 319.44% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | YARW total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -95.57% | 83.14% |
| Annualized return | -46.40% | 12.86% |
10Y · 2018-01-25 to 2026-08-27
| Metric | YARW total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.93% | 319.30% |
| Annualized return | -51.98% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |